0001104659-21-046191.txt : 20210402
0001104659-21-046191.hdr.sgml : 20210402
20210402180944
ACCESSION NUMBER: 0001104659-21-046191
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210402
DATE AS OF CHANGE: 20210402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dolan Daniel
CENTRAL INDEX KEY: 0001826818
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 21803257
MAIL ADDRESS:
STREET 1: C/O NABRIVA THERAPEUTICS PLC
STREET 2: 1000 CONTINENTAL DRIVE, SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER NAME:
FORMER CONFORMED NAME: Dolan Dan
DATE OF NAME CHANGE: 20200930
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2112032-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-03-31
0
0001641640
Nabriva Therapeutics plc
NBRV
0001826818
Dolan Daniel
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
Chief Financial Officer
Stock Option
1.66
2021-03-31
4
A
0
100000
0
A
2031-03-30
Ordinary Shares
100000
100000
D
The option was granted on March 31, 2021.
The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.
/s/ Robert Crotty, by power of attorney
2021-04-02